Finn's Take· TL;DRResearchers in Italy have discovered a potential association between the common erectile dysfunction drug Cialis (tadalafil) and muscle regeneration. It's a finding that sounds almost too convenient — a pill millions of men already take might also help fight one of aging's most stubborn problems: the gradual loss of muscle mass. But as with most things in early-stage science, the full picture is considerably more complicated.
The study, published in the journal Molecular Biology Reports, tested the drug on mouse muscle cells in a laboratory over a seven-day period, examining how it affected muscle cell growth, survival, and development. The research suggests that prolonged exposure to the drug can push skeletal muscle progenitor cells into a highly proliferative, regeneration-ready state, while simultaneously holding back their terminal differentiation.
Tadalafil was found to increase the number of muscle precursor cells, which are involved in the early stages of muscle formation, and helped more of them survive. The drug also showed signs of helping muscles repair themselves by encouraging growth and reducing cell death. That matters because these precursor cells are the raw material the body leans on when muscle needs to be repaired.
Despite these positive outcomes, the research found that tadalafil delayed the development of fully mature muscle cells. This suggests that the drug could create and maintain more cells involved in muscle regeneration, but does not indicate an increase in muscle size and function in humans. In other words, the pipeline may be fuller, but that doesn't mean the finished product is being delivered. As one outside expert explained, tadalafil helped muscle precursor cells grow and survive in mouse muscle cells studied in a laboratory, but also delayed their maturation into muscle fibers — and successful regeneration ultimately requires those cells to mature and form functional muscle tissue. That outcome was not established by this experiment.
Dr. Kien Vuu said the research is "worth studying" from a longevity perspective because age-related muscle loss contributes "significantly" to frailty, metabolic dysfunction, and loss of independence. That context gives the study its real-world weight. Sarcopenia — the clinical term for age-related muscle loss — affects a large portion of older adults and is linked to falls, hospitalizations, and reduced quality of life. Any drug that might slow that process would be enormously valuable.
Study co-author Dr. Cristina Antinozzi, a researcher in the Endocrinology Unit at the University of Rome Foro Italico, said these findings represent an "encouraging look at how tadalafil might be repurposed to support muscle tissue repair and regeneration." The study also highlighted the need to monitor how such mechanisms might be viewed or misused in sports and performance contexts.
As the study was conducted in mouse models, the results may differ when applied to humans, posing a limitation to the study findings. The study lasted just seven days, so more research is needed to understand the drug's long-term effects, the researchers acknowledged. These are significant caveats, and experts are emphatic that they matter.
Dr. Vuu added that tadalafil carries meaningful risks, including dangerous blood pressure reductions when combined with nitrates, and cautioned that people should not take the medication for muscle-building based on these findings — noting instead that resistance training, adequate protein, and quality sleep remain the most reliable ways to protect muscle with age. He stressed that this was a laboratory cell study, not a clinical trial, and that animal studies and eventually human trials examining actual muscle mass, strength, physical function, and safety are needed before drawing conclusions about clinical use. The science is intriguing — but it's still in its earliest chapter.